HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D L Becton Selected Research

Hemorrhage

5/2007Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D L Becton Research Topics

Disease

3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2002 - 09/2000
2Hemophilia A (Haemophilia)
05/2007 - 07/2006
1Hemorrhage
05/2007
1Down Syndrome (Down's Syndrome)
11/2002
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2000
1Leukemia
09/2000
1Myeloid Leukemia (Leukemia, Myelocytic)
09/2000

Drug/Important Bio-Agent (IBA)

1prothrombin complex concentrates (PPSB)IBA
05/2007
1Prothrombin (Factor II)IBA
05/2007
1anti-inhibitor coagulant complexIBA
05/2007
1Factor VIII (Coagulation Factor VIII)IBA
07/2006
1Cystathionine beta-Synthase (Serine Sulfhydrase)IBA
11/2002
1Etoposide (VP 16)FDA LinkGeneric
05/2002
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2002
1Mitoxantrone (Novantrone)FDA LinkGeneric
05/2002
1KRN 5500 (KRN5500)IBA
09/2000
1septacidinIBA
09/2000